
    
      This study is primarily an observational pilot study. After identifying patients as high-risk
      according to the following criteria: CAD and/or CVD and/or PAD and/or >=60 years old and at
      least 2 of the following - renal insufficiency, diabetes, COPD, hypertension, active smoker
      (or active within 6 months of consent), cancer, congestive heart failure, or any blood clot -
      they will be asked to sign a consent form. Patients surgical and hospital course will
      continue as per standard of care. Prior to surgery, 8ml of blood will be collected for to
      assess cardiovascular biomarkers including inflammatory, metabolic, hypercoagulable and
      platelet biomarkers to be tested independently in Dr. Berger's lab in Smilow. Study staff
      will perform electrocardiograms on POD 2. Results of these ECGs will not be placed in the
      patients' charts. No other procedures will be done for research purposes only.
    
  